Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
233
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
-1.99M
-
Total reported value, excl. options
-
$2.06B
-
Value change
-
-$111M
-
Put/Call ratio
-
0.54
-
Number of buys
-
129
-
Number of sells
-
-81
-
Price
-
$52.74
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2018
261 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2018.
REPLIGEN CORP - COMMON STOCK (RGEN) has 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 56.2M outstanding shares and own 69.38% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.58M shares), Vanguard Group Inc (4.03M shares), Invesco Ltd. (2.12M shares), WELLINGTON MANAGEMENT GROUP LLP (1.96M shares), STATE STREET CORP (1.94M shares), Conestoga Capital Advisors, LLC (1.62M shares), FRED ALGER MANAGEMENT INC (1.09M shares), MACQUARIE GROUP LTD (1.07M shares), DIMENSIONAL FUND ADVISORS LP (1.01M shares), and OppenheimerFunds, Inc. (994K shares).
This table shows the top 233 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.